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INTRODUCTION
Nanoparticles (NPs) owing to excellent features have 
continued to find relevance in different scientific domains 
such as medicine, food, cosmetics, textiles, etc. based on 
their size, distribution, and morphology (Sorescu et al. 
2016). They are very important because of the atom-like 
characteristics resulting from a large surface area to 
volume ratio among many others (Nithya and Kalyana-
sundharam 2019). Nanostructures, (NS) be it metallic 
(gold, silver, platinum, zinc, etc.) or their corresponding 
oxides such as zinc oxide are synthesised via physical, 
chemical, and biological methods. However, due to side 
effects resulting from chemical synthesis involving the 
use of dangerous chemicals leading to the release or 
production of environmentally unfriendly by-products, 
interest in an eco-friendly method found in biological 
procedures becomes germane (Ogunyemi et al. 2019).
The use of medicinal plants in the biosynthesis of NPs 
is a laudable and/ or better alternative aimed or embraced 
for the production of safe NS devoid of toxic substances. 
The reason for the medicinal plant usage or exploration 
has been attributed to the presence of functional groups 
arising from the inherent phytoconstituents such as 
phenols, flavonoids, alkaloids, amide, amine, terpenoids, 
etc. (Rai and Ingle 2012; Ogunyemi et al. 2019)
Zinc oxide, a metallic oxide NP, classed with the likes 
of Au, C, and graphene is regarded as a superior NS as 
a result of its wide and numerous applications in elec-
tronics, biology, medicine, communication, etc. In fact, 
immense progress on the use or application of this NP 
has continued to be felt particularly in the area of gene 
delivery, biological identification/labelling, drug develop-
ment/delivery, biological sensor, nanomedicine, optical/
chemical properties and so on. Additionally, the recent 
trend in the use of natural products in the synthesis of NPs 
had also been explored with ZnO. It is therefore interest-
ing to note that quite a number of plants including but 
not limited to Aloe barbadensis, Abutilon indicum, Solanum 
torvum, Laurus nobilis, Olea europaea, Hibiscus subdariffa, C. 
halicabum, Costus igneus, etc. have found their relevance 
as used in the ZnONPs synthesis (Sangeetha et al. 2011; 
Bala et al. 2015; Nithya and Kalyanasundharam 2019; 
Prashanth et al. 2018; Ezealisiji et al. 2019; Fakhari et al. 
2019; Ogunyemi et al. 2019; Vinotha et al. 2019)  with 
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established antibacterial, antioxidant and antidiabetic 
effects. Additionally, in the review compiled by Vishnu-
kumar and others (2018), it was evident that the part of 
plants mostly studied for ZnONPs applications is their 
leaves. Notwithstanding the afore-mentioned, very few 
reports are available in the literature on the antioxidative 
and antidiabetic effects of plant synthesised ZnONPs 
(Vishnukumar et al. 2018).
It is interesting to state that quite a number of studies 
centred on modifying the processes involved in the syn-
thesis of zinc oxide nanoparticles have been reported by 
various authors as cited in the work of Vishnukumar et al. 
(2018), these modifications were in an effort to establish 
methods with better potentials of the NPs. While some 
reports studied the impact of varying concentrations, 
different solvents (during synthesis), temperature, etc. 
on the crystallite size of the synthesised nanoparticles, 
others investigated the need to maintain the pH using 
NaOH to enhance the precipitation kinetics. To a very 
large extent, high concentration and temperature are 
opined to bring about a reduction in the (crystallite) size 
of the NPs while a NaOH mediated synthesis presented 
a larger size NS as witnessed in a study using Coriandrum 
sativum leaf extract.
In terms of application and/ or biomedical advance-
ment of phyto-synthesised ZnONPs, efforts on a number 
of plants had culminated into huge successes in diseases 
management (against free radical, cancer, bacterial and 
fungal infections, etc.), drug development, cosmetics, 
optical devices, solar cells, etc. (Vishnukumar et al. 2018). 
Lessertia montana (previously Sutherlandia montana), 
a member of the Fabaceae family is a South African 
indigenous plant whose ethnobotanical attributes and 
indigenous uses were well reported in the work of Ashafa 
et al. (2019). The pharmacological potentials of the leaf and 
whole plant as an anticancer, anti-stress, antidepressant, 
anti-HIV, antioxidant and antidiabetic are adequately 
submitted in the different reports and/ or reviews (van 
Wyk and Albrecht 2008; Aboyade et al. 2014). In fact, the 
phytochemical determination, antioxidative and antidia-
betic properties of the seeds, pods and leaf extracts of the 
plant were evaluated in our laboratory (Alimi and Ashafa, 
2018; Ashafa et al. 2019) and these studies revealed the 
superior pharmacological benefits of the leaves than other 
parts. Hence, this study was designed to investigate the 
antioxidant and antidiabetic potentials (in vitro) of zinc 
oxide nanoparticles synthesised from L. montana.
MATERIALS AND METHODS
Chemicals
Acarbose, quercetin, p-nitrophenyl-α-D-glucopyranoside 
(pNPG), porcine pancreatic α-amylase, rat intestinal 
α-glucosidase, 1, 1-diphenyl-2-picrylhydrazyl (DPPH) and 
2, 2′-Azino-bis(3-ethylbenzothiazoline-6-sulfonic acid 
(ABTS) were purchased from Sigma-Aldrich (South Africa) 
while zinc oxide was obtained from Merck Chemicals 
(South Africa). The water used was glass distilled while 
other chemicals/reagents used were of analytical grade.
Preparation of plant extracts
The whole plant of Lessertia montana was collected in 
Kestell, eastern Free State, South Africa. It was identified 
and authenticated by Prof Ashafa of the Plant Sciences 
Department at the University of the Free State and the 
voucher specimen (Alimed/01/2016/QHb) was deposited 
in the University herbarium.  The IUCN policy state-
ment on research concerning plant species at risk of 
extinction was adhered to and the plant was confirmed 
not to be near extinction as it was listed as a plant of the 
least concern according to the red list of plants by South 
Africa National Biodiversity Institute (SANBI) (http://
redlist.sanbi.org/genus.php?genus=3050). The leaves were 
separated from the whole plant, washed under running 
water, and air-dried at room temperature until the at-
tainment of uniform weight after 4 days. The dried leaf 
materials were afterward ground into powder using a 
laboratory blender (Warring Instrument, USA). The 
acquisition of the L. montana aqueous leaf extract accord-
ing to Ogunyemi et al. (2019) with slight modification 
was achieved by weighing 2 g of the samples in a 250 
mL conical flask and extracted with 200 mL distilled 
water. The flask containing the mixture was suspended 
on a heater with a magnetic stirrer (MSH 10, Labcon 
Consumables, South Africa) (6 g) exposed to heat at 65 
°C for 4 hours. The cooled mixture was filtered using 
adsorbent cotton wool followed by Whatman filter pa-
per No 1 and thereafter centrifuged (BHG Roto Uni II, 
Germany) (650 g) for 5 min to collect the supernatant 
used for the synthesis of ZnONPs.
Synthesis of ZnONPs
One hundred millilitres (100 mL) of zinc oxide (1 M) 
and freshly generated L. montana aqueous leaf extract 
(ratio 1:1) was mixed in a 200 mL conical flask, subjected 
to continuous agitation (10 g) at 70 °C for 4 hours to 
obtain NPs solution. The mixture was cooled at room 
temperature and centrifuged at 10000 g for 20 minutes 
and the residue, NPs pellets were washed four times with 
distilled water, dried at 50 °C and kept at -80 °C pending 
further characterisation and analysis (Ogunyemi et al. 





The synthesised Lessertia montana zinc oxide nanoparticles 
(LmZnONPs) was characterised (first of all) by measur-
ing and noting the point of optimum absorption using 
ultra-violet visible (UV) 5 Bio spectrophotometer (Metler 
Toledo, Switzerland) in the 100 – 800 nm range with aim 
of evaluating the optical property of the ZnONPs.
Scanning electron microscope (SEM) / energy-dispersive x-
ray spectroscopy (EDS)
The synthesised ZnONPs’ structural morphology and 
elemental composition were analysed with the use of SEM 
combined with energy dispersive spectrum (EDS) using 
Tescan Vega 3 SEM Oxford X-MaxN EDS equipment. A 
small quantity of synthesised L. montana ZnONPs powder 
was sparingly sprinkled on the carbon-coated copper grid 
and thereafter dried under mercury lamp for 10 minutes.
Fourier transform infrared spectroscopy (FT-IR)
Lessertia montana ZnONPs were subjected to the Fourier 
transform infrared (FTIR) machine, to have an insight 
about the functional biomolecules embedded in the syn-
thesised NPs and this, was achieved with the aid of 
Spectrum 100 series FTIR spectrometer (Perkin Elmer, 
Waltham, Massachusetts, United States). The sample was 
scanned (4 cm-1 resolution) in the spectra or wavelength 
range of 650-4000 cm-1 at room temperature.
X-ray diffraction (XRD)
The D8 advance diffractometer (Bruker AXS, Germany) 
using a LynxEye detector was used. The voltage set at 
40 kV, tube current 40 mA and Cu-Kα radiation (λKα1 
= 1.5406Å) was employed providing information about 
the morphology of the NPs. The recorded range of 2ϴ 
was 20-100 with a 0.5-second/step, equivalent to an ef-
fective time of 92 second/step for a scintillation counter. 
The Debye-Scherrer’s formula was used to estimate the 
crystallite particle sizes.
Antioxidant assays
The free radicals scavenging activities of the synthesised 
NPs were assessed using DPPH, ABTS, and metal chelat-
ing assays.
DPPH radical scavenging activity
The method of Braca et al. (2001) was adopted to deter-
mine the reduction of 1, 1-diphenyl-2-picrylhydrazyl 
(DPPH) radical by L. montana ZnONPs and other samples 
(extract, ZnO and quercetin) at various concentrations 
(0.125 – 1.000 g/L) prepared in 10% dimethyl sulfoxide 
(DMSO). Briefly, 0.1 mL of the samples were exposed to 
0.1 mL methanolic solution (0.004%) DPPH radical in 
a 96-well microtiter plate. Subsequently, the inhibition 
of the DPPH radical by the samples was viewed by the 
changes in colour from pink to yellow and golden follow-
ing 30 minutes incubation in the dark. The absorbance 
was measured at 517 nm. The percentage inhibition of 
the sample that scavenged DPPH radical was calculated 
using the expression [(A0–A1)/A0] x 100, where A0 is the 
absorbance of the control, and A1 is the absorbance of 
the sample. The half-maximal inhibitory concentration 
(IC50) values of the samples were calculated graphically 
and accordingly (Balogun and Ashafa 2016a).
ABTS radical determination
The ability of the samples to scavenge ABTS+ chromophore 
resulting from the reaction of ABTS solution with potas-
sium persulfate was determined based on Re et al. (1999) 
method. 50 mL of 7 mM aq. ABTS and 2.45 mM K2S2O7 
(50 mL) were prepared, reacted in the dark for 16 hours 
to produce an ABTS-K2S2O7 solution. Approximately 
0.2 mL of the solution was exposed to 0.02 mL aliquot 
of the sample and absorbance measured after 15 minutes 
of incubation at 734 nm using a BIO-RAD microplate 
reader (model 650, Japan).
Metal chelating activity
Dinis et al. (1994) protocol for determining the chelat-
ing capacity of a substance was used. One hundred µL 
L. montana ZnONPs and other samples at the tested 
concentrations were mixed with 0.5 mL 2 mM FeCl2 
solution and the reaction began with the addition of 0.2 
mL (5 mmol/L) ferrozine, shook vigorously and thereafter 
allowed to stand at room temperature for 600 seconds. 
The spectrophotometric measurement of the mixture 
was taken at 562 nm. The percentage inhibition of fer-
rozine–Fe2+ complex formation was determined from the 
expression [(A0–A1)/A0] x 100 as described above.
In vitro antidiabetic potentials
The alpha-amylase (α-AML) and alpha-glucosidase 
(α-GCD) assays were used to assess the antidiabetic 
activity (in vitro) of the green synthesised ZnONPs as 
presented in the reports of various authors below.
α-Amylase inhibitory assay
McCue and Shetty (2004) modified procedure was adopted 
in determining the inhibitory effect of α-AML by the L. 
montana zinc oxide nanoparticles. In brief, 50 μL of the 
samples (ZnONPs, extract, ZnO and acarbose) at ranging 
concentrations of 0.125 – 1.000 g/L were reacted with the 
same volume of α-AML prepared in sodium phosphate 
buffer (SPB; 0.02 M, pH 6.9) at a concentration of 0.5 g/L 
and pre-incubated at 25 °C for 10 minutes. Subsequently, 
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the addition of 50 μL of the 1% starch solution into the 
sample wells followed by 0.1 mL of di-nitro salicylic acid 
(DNS) reagent to stop the reaction and incubated at 25 
°C for another 10 minutes. The mixture was suspended 
in boiling water for 5 minutes, thereafter cooled, diluted 
with 1 mL distilled water (DW), and measured the ab-
sorbance at 540 nm. Distilled water replaced the extract 
to represent the control using the same protocol. The 
α-amylase inhibitory activity was calculated as percentage 
inhibition following the above expression [(A0–A1)/A0] x 
100 and the IC50 calculated graphically as defined in the 
report of Balogun and Ashafa (2016a).
Kinetics of α-amylase inhibition
The mode of α-AML inhibition by L. montana ZnONPs 
was evaluated according to Ali et al. (2006) method. The 
reaction mixture contained 0.25 mL synthesised ZnONPs 
(5 mg/mL) pre-incubated with 0.25 mL α- AML solution 
for 10 minutes at 25 °C in a set of 5 test tubes and  0.25 
mL phosphate buffer (PB) pre-incubated with 0.25 mL 
α-AML in another set of 5 test tubes. Thereafter, 0.25 mL 
starch solution in increasing concentrations (0.30 – 5.00 
gL-1) was dispensed in all test tubes to set the reaction in 
motion, followed by the introduction of DNS (0.02 mL) 
to bring the reaction to an end. The protocol continued 
as described above in the α-amylase inhibitory assay. 
Moreover, in an effort to determine the amount of reduc-
ing sugars released and converted to reaction velocities, 
a maltose standard curve was plotted, where the kinetics 
of inhibition of α-AML activity by synthesised ZnONPs 
was determined using Lineweaver and Burk (1934).
α-Glucosidase inhibitory assay
The antidiabetic effect of the L. montana ZnONPs was also 
assessed on the α-glucosidase enzyme using the procedural 
description of Kim et al. (2005) where the substrate, p-
nitrophenyl glucopyranoside (pNPG) (5 mM) used was 
prepared in 0.02 M phosphate buffer (pH 6.9). Fifty μL of 
the varying concentrations of the samples (0.125 – 1.000 
g/L) pre-incubated with 0.1 mL α-glucosidase (0.5 g/L) 
were mixed in a test tube. Fifty μL pNPG was afterward 
introduced into the reaction mixture to begin the reac-
tion while 2 mL Na2CO3 (0.1 M) was finally dispensed 
to stop the process followed by incubation at 37 °C for 
30 min. The α-glucosidase activity was determined by 
measuring the yellow-coloured para-nitrophenol (pNP) 
released from pNPG at 405 nm as the percentage inhibi-
tion determined by adopting the expression [(A0–A1)/A0] 
x 100 and the IC50 obtained as explained in the work of 
Balogun and Ashafa (2016a).
Mode of α-glucosidase inhibition
Ali et al. (2006) modified method was used to explore 
the kinetics of inhibition of the enzyme by synthesised 
ZnONPs. In summary, 0.05 mL (5 g/L) sample was diluted 
with 0.1 mL of α-GCD solution pre-incubated for 10 min-
utes at 25 °C in a set of five vials and concurrently, α-GCD 
solution reacted with 0.05 mL phosphate buffer (pH 6.9) 
in another set of 5 vials. Subsequently, fifty microliters 
pNPG in ascending concentrations (0.125 – 2.000 g/L) 
was introduced to the two sets of test vials to kick-start 
the reaction process and the mixture allowed to incubate 
at 25 °C for 10 minutes. Finally, the reaction was termi-
nated with 0.5 mL of Na2CO3. A para-nitrophenol (p-NP) 
standard was used to depict spectrophotometrically the 
amount of reducing sugars released and kinetics of L. 
montana ZnONPs on the α-glucosidase activity determined 
using Michaelis-Menten kinetics.
Statistical analysis
Data analyses were carried out by one-way analysis of 
variance (ANOVA), followed by Bonferroni’s multiple 
comparison test. Results expressed as mean ± standard 
error of mean (SEM) using Graph pad Prism version 3.0 
for Windows, Graph Pad Software, SanDiego, California, 
USA.
RESULTS AND DISCUSSION
The simplicity, stability, affordability, and eco-friendliness 
of the synthesised NPs from medicinal plants afford great 
relevance to the biological methods in nanotechnology, 
hence the acceptability in drug discovery and development 
(Sun et al. 2019). The antioxidant and antihyperglycaemic 
potentials of the aqueous leaf extract of Lessertia montana 
(Alimi and Ashafa 2017) propelled undertaking the study 
to evaluate the effect of the synthesised nanoparticle (Les-
sertia montana ZnONPs) on these disease conditions. In the 
work of Alimi and Ashafa (2017), various phytochemicals 
such as alkaloids, flavonoids, phenols, saponins, etc. are 
detected in the aqueous extract of the leaf and in fact, these 
phytoconstituents are regarded as polyphenols (Ezealisiji 
et al. 2019) and also depicted by the various functional 
groups on the FTIR spectrum. Therefore, the probable 
mechanism of ZnONPs synthesis from L. montana entails 
the reaction of Zn2+ in the solution with the polyphenols 
(flavonoids, alkaloids, phenols) in the extract resulting in 
the reduction of the Zn2+ to ZnO, which on complexation 
will (at the end of the reaction) form ZnONPs (Basneth 
et al. 2018; Ogunyemi et al. 2019; Ezealisiji et al. 2019).
The zinc oxide nanoparticles synthesised using L. 
montana leaves extract was observed to give a light-yel-
low precipitate, dried to obtain ZnO nanopowder used 
in the characterisation processes (CP). The CP was in-
itiated with a UV-Vis spectrophotometer to determine 
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the region of optimum absorption of the ZnONPs (Fig. 
1) observed at a wavelength range of 387.5 nm (Fig. 1) 
after being monitored on the spectra range between 
100 - 800 nm. The observed absorbance value aligned 
with the reports of previous authors who submitted the 
maximum absorption of ZnO to be in 380-387 range 
(Nithya and Kalyanasundharam 2018; Mohammadian et 
al. 2018; Ogunyemi et al. 2019). However, it must be noted 
that the differences in the absorption of a substance and 
in this case, ZnO nanoparticle is dependent on several 
factors including synthesis procedure, particle size, shape, 
contamination, and so on. Intriguingly, the observed 
absorption of L. montana ZnONPs at 387 nm was in line 
with the submission of Nithya and Kalyanasundharam 
(2019) for C. halicacabum leaf. Additionally, the energy of 
the bandgap was calculated from the expression E = hv 
= hf = hc/λ since f = c/λ
Where ‘h’ denotes the Plank’s constant, ‘c’ signify the 
speed of light while ‘λ’ connotes the wavelength
The optical band gap energy for L. montana ZnONPs 
was calculated to be 3.2 eV. It is worthy of mention 
that different studies have reported different values for 
ZnONPs. In a study, it is submitted at 3.88 eV (Ogunyemi 
et al. 2019), whereas other reports maintained that it 
varies between 3.1 to 3.3 eV (Srikant and Clarke, 1998) 
and 3.16 - 3.22 eV (Ramesh et al. 2014; Rehana et al. 2017) 
while others (Vishnukumar et al. 2018; Kalpana and 
Devi Rajeswari 2018) established it at 3.3 eV and 3.37 eV, 
respectively. However, variation in band gap energy has 
been suggested to be due to valence band-donor transition 
overpowering the optical absorption (Srikant and Clarke 
1998). The obtained value for the study was in agreement 
with the report of Ramesh et al. (2014).
Fourier transform infrared spectroscopy was per-
formed on the synthesised ZnONPs with the view to 
depict the likely functional groups or the phytochemi-
cals acting as capping and stabilizing agents. FTIR was 
similarly undertaking to express the vibrational and 
rotational motion of the concerned molecule. Thus, the 
FTIR spectrum for L. montana ZnONPs revealed a peak 
at 3365 cm-1 corresponding to the O-H stretching of 
hydroxyl groups. Bayrami et al. (2020) citing from the 
work of Sundrarajan et al. (2015) submitted that peaks 
in the region of 3700 to 3300 are due to O-H stretch-
ing vibration.  Peaks at 2945 cm-1, 1412 cm-1 1046 cm-1 
corresponded to broad bands of medium C-H (Bayrami 
et al. 2020), strong C-C and strong, broad CO-O-CO 
stretching due to alkanes, aromatic group (Elumalai et al. 
2015; Rehana et al. 2017), and anhydride respectively. The 
peak at 1596 cm-1 corresponds to medium N-H bending 
due to amine region, 892 cm-1 corresponded to strong 
C=C bending due to alkene (vinylidene) and 699 cm-1 due 
to strong C=C bending due to alkene (cis disubstituted) 
(Fig. 2). The reports of Alimi and Ashafa (2017), as well as 
Ashafa et al. (2019), reported various phytochemicals such 
as alkaloids, flavonoids, phenolics, tannins, triterpenes, 
phytosterols, and cardiac glycosides. Interestingly, most 
of these functional groups observed in the FTIR spectra 
underlie these phytochemicals. Typically, alkaloids contain 
nitrogen groups such as amide; phenols and flavonol (a 
class of flavonoids) bear OH groups attached to the aro-
matic ring structures. In line with the aforementioned, 
the presence of these functional groups in the spectrum is 
indicative that these secondary metabolites bond strongly 
to ZnONPs despite several washing, hence, the possible 
association between the phytoconstituents and surface 
of the Zn resulting in the potential conversion of ZnO 
Figure 1. UV-Vis spectra of synthesised L. montana ZnONPs showing 
the maximum absorbance at 387.5 nm.
Figure 2. Fourier transform infrared (FTIR) spectra of L. montana 
ZnONPs showing various prominent peaks.
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to ZnONPs while maintaining the stability of ZnONPs 
(Rajakumar et al. 2018).
The use of the SEM technique on a substance accords 
information on the morphology of the substance and in our 
case, the synthesised ZnO nanostructures. In the present 
study, a critical view of the NPs morphology indicated a 
mixture of cubical and spherical structures which was in 
agreement with the work of Rajakumar et al. (2018) though 
the presence of the cubic-like structures were more (Fig. 
3A, 3B and 3C) with varying size ranging from 154.78 to 
521.47 nm (Fig. 3B). The energy dispersive spectra (EDS) 
provided details on the composition of the elements, i.e. 
zinc and oxygen involved in the compound ZnO or the 
stoichiometric ratio, found to be 82.6 and 17.4 proportion 
respectively in this study (Fig. 4). The observed revelation 
is indicative of the usage of an analytical grade of zinc 
oxide (chemical) powder (Kumar et al. 2013; Ogunyemi 
et al. 2019) for the L. montana ZnONPs synthesis. Inter-
estingly, the EDS spectrum showed the presence of other 
elements including nitrogen and carbon, which could be 
attributed to the endowed bioactive constituents available 
in L. montana plant and responsible for the stabilization of 
ZnONPs as established in the report of Bala et al. (2015).
Fig. 5 showed prominent peaks (arising from ZnO) 
positioned at various 2ϴ values 31.8, 34.4, 36.3, 47.5, 56.6, 
62.9, 66.4, 68.0, 69.1, 72.6, 77.0 and 81.4 degrees which 
correspond to ‘hkl’(miller indices) crystal planes of 100, 
002, 101, 102,110, 103, 200, 112, 201, 004, 202 and 104, 
respectively. The Scherer equation adopted to evaluate 
the green synthesised ZnONPs crystallite size as shown 
in the expression below:
D = Kλ/βCosϴ
Where D represent the crystallite size, K is the shape 
factor (constant) and equals 0.94, λ is the x-ray wavelength 
(1.5406Å) and β is the full width at half maximum of the 
dominant or peak of interest. Thus, the D values for the 
L. montana ZnONPs visible peaks are 27.3, 24.8, 23.3, 14.7, 
11.6, 8.6, 7.3, 11.0, 9.6, 11.3, 7.9 and 8.6 nm, respectively. 
These values (sizes) are smaller as compared to the SEM 
(larger size) report, attributed to the agglomeration of the 
smaller size particles (Ogunyemi et al. 2019) particularly 
if the synthesis occurs in an aqueous medium (Rajakumar 
et al. 2018) as achieved in this study. The crystallite sizes 
ranged between 7.3 to 27.3 nm with an average size of 
Figure 3. A, B and C are SEM pictures of synthesised L. montana ZnONPs at 2 µm, 1 µm and 500 nm, respectively.
Table 1. Free radicals potentials and metal chelating effect of synthesised L. montana ZnONPs.
Parameters IC50 (g/L)
L. montana ZnONPs L. montana ZnO Quercetin
DPPH 0.120 ± 1.42a* 0.261 ± 1.55b 1.165 ± 5.60c 0.349 ± 4.27d
ABTS 0.711 ± 8.07a 0.964 ± 7.27b 1.166 ± 9.45c 0.093 ± 3.77d
Metal chelating 0.184 ± 5.94a 0.554 ± 3.00b 0.591 ± 3.15c 0.027 ± 9.87d
ZnONPs: zinc oxide nanoparticles; DPPH: 1,1-diphenyl-2-picrylhydrazyl; ABTS: 2,2-azino benzothiazolidine(-6-sulphonic) acid; ZnO: zinc oxide
*Values with different superscript letters along the same column for each parameter are significantly different (p < 0.05) from each other
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13.8 nm. Interestingly, very few studies on ZnO using 
medicinal plants have this type of very small nano-sized 
particles. Smaller-sized nanoparticles are endowed with 
larger surface area to volume ratio, which enhances their 
binding to cell’s surface, according them a great deal of 
preference in biological applications (Rehana et al. 2017; 
Vishnukumar et al. 2019).  
The negative consequences of free radicals have ne-
cessitated research into this field (free radical chemistry). 
Free radicals (FRs) are reactive oxygen or nitrogen species 
produced by the body on exposure to diseased state (Lobo 
et al. 2010). It must be noted that FRs are not necessarily 
bad but excessive production in the body system is what 
must be guided against. Hence, equilibrium between 
FRs and the body’s antioxidant defence mechanism must 
be maintained for the proper functioning of the cells, 
otherwise, it results in a state of oxidative stress, which 
means the defence mechanism of the body is overpowered 
or compromised and ultimately result into cell death. 
Thus, prompt intervention with the use of antioxidants 
(synthetic or natural) is necessary (Balogun and Ashafa 
2016b). In an effort to study the effect of antioxida-
tive substances on free radicals, various in vitro (DPPH, 
ABTS, hydroxyl radicals, superoxide anions, etc.) and in 
vivo methods are adopted by researchers. In this study, 
the antioxidative potential of the synthesised NPs was 
evaluated on DPPH and ABTS as well as metal chelating. 
It was observed that going by half-maximal inhibitory 
concentration results, L. montana ZnONPs performed 
exceedingly well (p < 0.05) in all the assays including DPPH 
(120.31 µg/mL), ABTS (711.45 µg/mL) and metal chelat-
ing (184.16 µg/mL) when compared with other samples 
(extract, ZnO and quercetin) except with ABTS and metal 
chelating where the control, quercetin displayed better (p 
< 0.05) activity (93.94, 27.81 µg/mL, respectively) which 
is expected (Table 1). The excellent activity observed by 
synthesised ZnONPs against DPPH as reflected in the 
colour change from pink to yellow is an indication of its 
potential in reducing stable DPPH with its hydrogen ion 
donating-ability. DPPH method is the most important 
assay for the determination of the antioxidant potential 
of a substance or compound (followed by ABTS assay) 
(Sanchez-Moreno et al. 1999; Sagar and Ashok 2012). The 
mechanism of action is that the antioxidant substance 
donates hydrogen atom to the radical (DPPH) with an 
Figure 4. Energy dispersive spectra (EDS) of the synthesised L. montana ZnONP showing the elemental composition of ZnO in the nanostructures 
(left) and the corresponding image (right).
Figure 5. XRD spectrum of synthesised L. montana ZnONPs.
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unbalanced shell electron, resulting in the reduction or 
reduced form of the radical, and when this is achieved, 
the pink colour of the radical changes to yellow. Sum-
marily, since the introduction of antioxidant substance 
cushions or fortifies the weakened defence mechanism 
preventing cell death (Lewinski et al. 2008; Lobo et al. 
2010), L. montana ZnONPs may be suggested to exhibit 
a similar role. Interestingly, these findings corroborate 
the reports of similar studies where synthesised ZnONPs 
from medicinal plants inhibits the activities of the studied 
radicals. Typically, the activity of Costus igneus aqueous 
leaf (20-100 µg/mL) extracts was compared with Ci-ZnO 
(nanoparticle) against DPPH and was found to depict 75% 
inhibition as compared with extract alone having 55% 
(Vinotha et al. 2019). Additionally, in a study by Rehana 
et al. (2017), where the free radical scavenging potentials 
of five plants (A. indica, H. rosa-sinensis, M. koenigi, M. ole-
ifera, and T. indica) used in the synthesis of ZnONPs were 
tested against ABTS, DPPH, hydroxyl radical, superoxide 
radical and hydrogen peroxide revealed significant ac-
tivities better than standards (ascorbic acids and rutin) 
(Rehana et al. 2017). A similar trend was also reported 
in the work of Rajakumar et al. (2018) with Andrographis 
paniculata leaf ZnONPs curbing the activities of DPPH, 
reducing power and nitric oxide.
Diabetes mellitus is a chronic metabolic disease char-
acterised by hyperglycaemia due to abnormalities in pro-
tein, carbohydrate, and lipids metabolism resulting from 
ineffective insulin or insulin-resistant or both (Krentz 
and Bailey 2005; Rehana et al. 2017). During postprandial 
hyperglycaemia, the utmost management approach of the 
ailment is to inhibit the constant production of glucose 
(available in the blood) aided by hydrolysing enzymes 
such as alpha-amylase (found in the pancreas) and alpha-
glucosidase (found in the brush border of the intestine) 
(Balogun and Ashafa 2017). Notable inhibitors of these 
enzymes are acarbose, miglitol, and so on, which act by 
slowing down the persistent hydrolysis of starch to pro-
duce glucose. Sadly, these inhibitors come with side effects 
such as gastrointestinal (GIT) discomfort, bloating, etc., 
hence, looking for an alternative inhibitor from natural 
products without side effects becomes germane (Sathya 
and Siddhuraju 2012; Rehana et al. 2017). Moreover, it is 
important to state that any inhibitor with this feature must 
be able to inhibit alpha-amylase mildly while inhibiting 
alpha-glucosidase strongly. A view of the antidiabetic 
result from the study showed that the L. montana aque-
ous extract (0.197 g/L) and synthesised ZnONPs (0.037 
g/L) revealed the best potential at significantly (p < 0.05) 
inhibiting the activities of α-amylase and α-glucosidase 
respectively when compared with other samples and 
standard, acarbose (0.594 and 0.065 g/L, respectively). 
Intriguingly, as reiterated above, L. montana ZnONPs 
showed a character depicted of a good antihyperglycaemic 
agent with the lowest IC50 value (0.037 g/L) against alpha-
glucosidase (strongest inhibition) and highest IC50 value 
(0.620 g/L) against alpha-amylase (mildest inhibition) 
(Table 2). The result is in tandem with the revelation from 
Rehana et al. (2017) where T. indica ZnONPs exhibited the 
highest inhibitory concentration against alpha-amylase 
and alpha-glucosidase enzymes as compared with other 
four plants, whose inhibitions are better than ZnONPs 
synthesised by chemical method. Moreover, too, ZnONPs 
synthesised by A. paniculata revealed a moderate alpha-
amylase activity, which was better than the extract coun-
terpart (Rajakumar et al. 2018). 
In this study, the likely mode of inhibition for α-amylase 
by L. montana ZnONPs established a constant Vmax value 
Figure 6. A competitive inhibition of alpha-amylase (A) and non-
competitive inhibition of alpha-glucosidase (B) by L. montana ZnONPs.
Parameters IC50 (g/L)
L. montana ZnONPs L. montana ZnO Acarbose
α-amylase 0.620 ± 3.35a* 0.196 ± 3.39b 0.300 ± 5.37c 0.594 ± 1.48d
α-glucosidase 0.037 ± 7.48a 0.095 ± 7.38b 0.119 ± 4.23c 0.065 ± 5.38d
Table 2. Inhibitory activities of synthesised L. montana ZnONPs on hydrolysing enzymes of carbohydrates.
ZnONPs: Zinc oxide nanoparticles; ZnO: Zinc oxide.
*Values with different superscript letters along the same column for each parameter are significantly different (p<0.05) from each other
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(0.0021 mM/min) between the control and NPs with a 
decreased Km values from 0.579 mM-1 (control) to 0.116 
mM-1 (L. montana ZnONPs) signifying a competitive 
inhibition (Fig. 6A). The implication of this is that syn-
thesised L. montana ZnONPs competed with the substrate 
at binding at the active site of the enzyme, thus slowing 
down the conversion of carbohydrate to disaccharides. 
On the other hand, a constant Km value (0.14 mM-1) and 
a decreased Vmax values from 0.066 mM/min to 0.015 
mM/min for alpha-glucosidase thus, depicting a non-
competitive inhibition (Fig. 6B). This thus indicates that 
L. montana ZnONPs possibly binds to a site apart from 
the active site of the enzyme thereby binding with either 
free enzyme or enzyme-substrate complex interfering 
with the action of both (Mayur et al. 2010).
CONCLUSION
The Lessertia montana synthesised zinc oxide nanoparticles, 
no doubt, revealed good antioxidative and antidiabetic 
potentials which could be attributed to the presence of 
phytonutrients. Hence, the need to embrace plant-derived 
nanoparticles becomes vital, not only because of its low 
cost of synthesis, environment friendliness etc. but ow-
ing to the enhanced activity as compared with the bulk 
extract (as depicted in this study). Furthermore, the 
relatively small size of NPs, which would aid effective 
absorption or penetration into cells, including possible 
interaction with the cell surface of biomolecules in order 
to elicit adequate cellular responses would be preferable 
for biological applications.  
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